Four-component synthesis of 1,2-dihydropyridine derivatives and their evaluation as anticancer agents. 2012

Mohamed A O Abdel-Fattah, and Mahmoud A M El-Naggar, and Rasha M H Rashied, and Bernard D Gary, and Gary A Piazza, and Ashraf H Abadi
Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt.

Two series of compounds with the general formula of 4,6-diaryl-2-oxo-1,2 dihydropyridine-3-carbonitriles and their isosteric imino derivatives were synthesized through a one pot reaction of acetophenone, aldehyde and ammonium acetate with ethyl cyanoacetate or malononitrile, respectively. The synthesized compounds were evaluated for tumor cell growth inhibitory using the human HT-29 colon and MDA-MB-231 breast tumor cell lines. Compound 4-(2- Ethoxyphenyl)-2-imino-6-(4-fluorophenyl)-1,2-dihydropyridine-3 carbonitrile (6) showed IC50 value of 0.70 μM versus HT-29. Meanwhile, compound 4-(2-Hydroxyphenyl)-2-imino-6-(4-fluorophenyl)-1,2-dihydropyridine-3-carbonitrile (4) showed IC50 value of 4.6 μM versus MDA-MB-231. Docking compound 10 to possible molecular targets, survivin and PIM1 kinase showed appreciable interactions with both, which suggest possible targets for the antitumor activity of this novel class of anticancer compounds.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D004095 Dihydropyridines Pyridine moieties which are partially saturated by the addition of two hydrogen atoms in any position.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Mohamed A O Abdel-Fattah, and Mahmoud A M El-Naggar, and Rasha M H Rashied, and Bernard D Gary, and Gary A Piazza, and Ashraf H Abadi
May 2013, Archiv der Pharmazie,
Mohamed A O Abdel-Fattah, and Mahmoud A M El-Naggar, and Rasha M H Rashied, and Bernard D Gary, and Gary A Piazza, and Ashraf H Abadi
January 2021, Frontiers in chemistry,
Mohamed A O Abdel-Fattah, and Mahmoud A M El-Naggar, and Rasha M H Rashied, and Bernard D Gary, and Gary A Piazza, and Ashraf H Abadi
October 2010, Chemical & pharmaceutical bulletin,
Mohamed A O Abdel-Fattah, and Mahmoud A M El-Naggar, and Rasha M H Rashied, and Bernard D Gary, and Gary A Piazza, and Ashraf H Abadi
February 2018, Molecules (Basel, Switzerland),
Mohamed A O Abdel-Fattah, and Mahmoud A M El-Naggar, and Rasha M H Rashied, and Bernard D Gary, and Gary A Piazza, and Ashraf H Abadi
October 2012, Organic & biomolecular chemistry,
Mohamed A O Abdel-Fattah, and Mahmoud A M El-Naggar, and Rasha M H Rashied, and Bernard D Gary, and Gary A Piazza, and Ashraf H Abadi
September 2015, Chemical biology & drug design,
Mohamed A O Abdel-Fattah, and Mahmoud A M El-Naggar, and Rasha M H Rashied, and Bernard D Gary, and Gary A Piazza, and Ashraf H Abadi
October 2015, Molecules (Basel, Switzerland),
Mohamed A O Abdel-Fattah, and Mahmoud A M El-Naggar, and Rasha M H Rashied, and Bernard D Gary, and Gary A Piazza, and Ashraf H Abadi
January 2016, Molecules (Basel, Switzerland),
Mohamed A O Abdel-Fattah, and Mahmoud A M El-Naggar, and Rasha M H Rashied, and Bernard D Gary, and Gary A Piazza, and Ashraf H Abadi
March 2010, Oncology letters,
Mohamed A O Abdel-Fattah, and Mahmoud A M El-Naggar, and Rasha M H Rashied, and Bernard D Gary, and Gary A Piazza, and Ashraf H Abadi
January 2016, European journal of medicinal chemistry,
Copied contents to your clipboard!